Xylem
XYL
101.82
-2.75
-2.63%
Xylem
US · XYL
#827 by market cap
Listed 1970
101.82
-2.75
-2.63%
Live - 5344 symbols - heartbeat 159s ago
· 2026-10-08 08:16
Pre-market
101.16
-0.65%
After-hours
101.82
0.00%
Overnight
101.59
-0.23%
- Market cap
- 23.77B
- P/E (TTM)i
- 24.24
- P/Bi
- 2.28
- EPSi
- 3.92
- Div yieldi
- 1.63%
- 52W posi
- 6%
Reader sentiment
Are you bullish or bearish on XYL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.60, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.52% YoY
Margins
- Gross margin
- 38.46%
- Operating margin
- 14.68%
- Net margin
- 10.59%
Key ratios & quality
- Enterprise valuei
- 24.36B
- PEG ratioi
- 0.62
- Altman Z-Scorei
- 3.60
PEG uses trailing P/E against the 3-year net income growth rate (39.18%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.21B | 5.25B | 4.88B | 5.20B | 5.52B | 7.36B | 8.56B | 9.04B |
| Gross profit | 2.03B | 2.05B | 1.83B | 1.98B | 2.08B | 2.72B | 3.21B | 3.48B |
| Selling & admin expenses | 1.16B | 1.16B | 1.14B | 1.18B | 1.23B | 1.76B | 1.91B | 1.92B |
| Research & development | 189.00M | 191.00M | 187.00M | 204.00M | 206.00M | 232.00M | 230.00M | 226.00M |
| Operating profit | 676.00M | 697.00M | 500.00M | 592.00M | 651.00M | 728.00M | 1.07B | 1.33B |
| Pretax profit | 585.00M | 416.00M | 285.00M | 511.00M | 440.00M | 635.00M | 1.09B | 1.18B |
| Tax | 36.00M | 15.00M | 31.00M | 84.00M | 85.00M | 26.00M | 197.00M | 231.00M |
| Net profit | 549.00M | 401.00M | 254.00M | 427.00M | 355.00M | 609.00M | 890.00M | 950.00M |
| Basic EPS | 3 | 2 | 1 | 2 | 2 | 3 | 4 | 4 |
| Diluted EPS | 3.03 | 2.21 | 1.40 | 2.35 | 1.96 | 2.79 | 3.65 | 3.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.07B | 2.30B | 2.27B | 2.40B | 2.13B | 2.34B |
| Gross profit | 768.00M | 892.00M | 883.00M | 932.00M | 803.00M | 963.00M |
| Selling & admin expenses | 460.00M | 503.00M | 474.00M | 486.00M | 472.00M | 503.00M |
| Research & development | 56.00M | 58.00M | 52.00M | 60.00M | 56.00M | 59.00M |
| Operating profit | 252.00M | 331.00M | 357.00M | 386.00M | 275.00M | 401.00M |
| Pretax profit | 217.00M | 299.00M | 297.00M | 368.00M | 244.00M | 364.00M |
| Tax | 50.00M | 75.00M | 71.00M | 35.00M | 55.00M | 103.00M |
| Net profit | 167.00M | 224.00M | 226.00M | 333.00M | 189.00M | 261.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.69 | 0.93 | 0.93 | 1.37 | 0.79 | 1.11 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.09B | 2.45B | 3.52B | 3.16B | 3.01B | 3.88B | 4.10B | 4.64B |
| Cash & ST investments | 296.00M | 724.00M | 1.88B | 1.35B | 944.00M | 1.02B | 1.12B | 1.48B |
| Inventory | 595.00M | 539.00M | 558.00M | 700.00M | 799.00M | 1.02B | 996.00M | 983.00M |
| Total assets | 7.22B | 7.71B | 8.75B | 8.28B | 7.95B | 16.11B | 16.49B | 17.63B |
| Total current liabilities | 1.39B | 1.50B | 1.96B | 1.39B | 1.59B | 2.21B | 2.34B | 2.86B |
| Short-term debt | 257.00M | 337.00M | 663.00M | 69.00M | 69.00M | 122.00M | 147.00M | 655.00M |
| Long-term debt | 2.05B | 2.04B | 2.48B | 2.44B | 1.88B | 2.27B | 1.98B | 1.41B |
| Total liabilities | 4,440,000,000.00 | 4,743,000,000.00 | 5,774,000,000.00 | 5,050,000,000.00 | 4,449,000,000.00 | 5,936,000,000.00 | 5,611,000,000.00 | 5,885,000,000.00 |
| Total equity | 2.78B | 2.97B | 2.98B | 3.23B | 3.50B | 10.18B | 10.88B | 11.75B |
| Retained earnings | 1.64B | 1.87B | 1.93B | 2.15B | 2.29B | 2.60B | 3.14B | 3.71B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.08B | 4.37B | 4.44B | 4.64B | 4.03B | 4.39B |
| Cash & ST investments | 1.06B | 1.17B | 1.19B | 1.48B | 808.00M | 1.28B |
| Inventory | 1.02B | 1.07B | 1.04B | 983.00M | 991.00M | 1.02B |
| Total assets | 16.56B | 17.19B | 17.30B | 17.63B | 16.95B | 17.34B |
| Total current liabilities | 2.17B | 2.30B | 2.27B | 2.86B | 2.76B | 2.72B |
| Short-term debt | 162.00M | 196.00M | 176.00M | 655.00M | 654.00M | 660.00M |
| Long-term debt | 1.97B | 1.93B | 1.91B | 1.41B | 1.41B | 2.40B |
| Total liabilities | 5,505,000,000.00 | 5,882,000,000.00 | 5,850,000,000.00 | 5,885,000,000.00 | 5,725,000,000.00 | 6,676,000,000.00 |
| Total equity | 11.05B | 11.31B | 11.45B | 11.75B | 11.23B | 10.67B |
| Retained earnings | 3.21B | 3.34B | 3.47B | 3.71B | 3.79B | 3.96B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 586.00M | 839.00M | 824.00M | 538.00M | 596.00M | 837.00M | 1.26B | 1.24B |
| Depreciation & amortization | 261.00M | 257.00M | 251.00M | 245.00M | 236.00M | 436.00M | 562.00M | 575.00M |
| Free cash flow | 349.00M | 613.00M | 641.00M | 330.00M | 388.00M | 566.00M | 942.00M | 910.00M |
| Dividends paid | -152.00M | -174.00M | -188.00M | -203.00M | -217.00M | -299.00M | -350.00M | -391.00M |
| Stock buybacks / issuance | -59.00M | -40.00M | -61.00M | -68.00M | -52.00M | -25.00M | -20.00M | -15.00M |
| Ending cash balance | 296.00M | 724.00M | 1.88B | 1.35B | 944.00M | 1.02B | 1.12B | 1.48B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 33.00M | 305.00M | 360.00M | 543.00M | 108.00M | 290.00M |
| Depreciation & amortization | 145.00M | 145.00M | 142.00M | 143.00M | 140.00M | 140.00M |
| Free cash flow | -38.00M | 207.00M | 281.00M | 460.00M | 18.00M | 201.00M |
| Dividends paid | -98.00M | -98.00M | -97.00M | -98.00M | -106.00M | -101.00M |
| Stock buybacks / issuance | -13.00M | 0 | -1.00M | -1.00M | -563.00M | -680.00M |
| Ending cash balance | 1.06B | 1.17B | 1.19B | 1.48B | 808.00M | 1.28B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 20.83 | 14.01 | 8.57 | 13.81 | 10.58 | 8.92 | 8.55 | 8.65 |
| ROA %i | 7.80 | 5.37 | 3.09 | 5.02 | 4.38 | 5.06 | 5.46 | 5.61 |
| ROIC %i | 12.40 | 8.85 | 5.53 | 8.19 | 6.85 | 6.99 | 7.13 | 7.29 |
| 5-year avg ROE %i | 15.74 | 15.45 | 13.94 | 14.27 | 13.56 | 11.18 | 10.09 | 10.10 |
| EBIT margin %i | 12.81 | 9.20 | 7.42 | 11.30 | 8.87 | 9.29 | 13.21 | 13.39 |
| FCF / sales %i | 6.70 | 11.68 | 13.15 | 6.35 | 7.03 | 7.69 | 11.00 | 10.07 |
| Current ratioi | 1.51 | 1.63 | 1.80 | 2.27 | 1.89 | 1.76 | 1.75 | 1.63 |
| Quick ratioi | 0.96 | 1.17 | 1.43 | 1.65 | 1.28 | 1.20 | 1.19 | 1.13 |
| Debt / assetsi | 31.96 | 30.83 | 35.97 | 30.32 | 24.51 | 14.83 | 12.88 | 11.70 |
| LT debt / equityi | 74.10 | 68.99 | 83.69 | 75.82 | 53.81 | 22.31 | 18.59 | 12.26 |
| Interest coveragei | 8.13 | 7.21 | 4.70 | 7.72 | 9.80 | 13.96 | 25.70 | 41.72 |
| Revenue CAGR (3Y) %i | 12.54 | 11.65 | 1.18 | -0.08 | 1.70 | 14.73 | 18.12 | 17.84 |
| Net income CAGR (3Y) %i | 17.32 | 15.54 | -8.45 | -8.04 | -3.98 | 33.84 | 27.74 | 39.18 |
| FCF CAGR (3Y) %i | 0.19 | 18.01 | 7.50 | -1.85 | -14.14 | -4.06 | 41.86 | 32.86 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.62 | 8.76 | 8.70 | 8.65 | 9.01 | 9.47 |
| ROA %i | 5.58 | 5.69 | 5.69 | 5.61 | 5.85 | 5.90 |
| ROIC %i | 7.34 | 7.54 | 7.49 | 7.29 | 7.71 | 7.77 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 13.33 | 13.70 | 13.72 | 13.39 | 13.56 | 14.20 |
| FCF / sales %i | 10.34 | 10.09 | 10.40 | 10.07 | 10.63 | 10.52 |
| Current ratioi | 1.89 | 1.90 | 1.96 | 1.63 | 1.46 | 1.61 |
| Quick ratioi | 1.29 | 1.31 | 1.32 | 1.13 | 0.95 | 1.16 |
| Debt / assetsi | 12.90 | 12.36 | 12.08 | 11.70 | 12.16 | 17.62 |
| LT debt / equityi | 18.25 | 17.41 | 17.07 | 12.26 | 12.82 | 22.98 |
| Interest coveragei | 30.16 | 33.22 | 38.13 | 41.72 | 49.32 | 56.35 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Water Infrastructure is the largest reported line at 29.24% of revenue, across 4 reported segments.
- No single line clears half of revenue; Water Solutions and Services is next at 27.57%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Water Infrastructure29.24%
Water Solutions and Services27.57%
Measurement and Control Solutions21.75%
Applied Water21.45%
Quote time 2026-10-08 08:16:31 · For reference only, not investment advice and not tailored to your situation.